Celularity Inc. Payments of Debt Issuance Costs
Celularity Inc. (CELU) reported Payments of Debt Issuance Costs of $40.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-04-30
- Celularity Inc. payments of debt issuance costs for the quarter ending 2023-12-31 was $0.00.
- Celularity Inc. payments of debt issuance costs for the quarter ending 2023-09-30 was $260.00K, a 12.55% increase year-over-year.
- Celularity Inc. payments of debt issuance costs for the quarter ending 2022-12-31 was -$150.00K, a 110.50% decline year-over-year.
- Celularity Inc. payments of debt issuance costs for the quarter ending 2022-09-30 was $231.00K, a 93.57% decline year-over-year.
- Celularity Inc. payments of debt issuance costs for fiscal 2025 was $40.00K.
- Celularity Inc. payments of debt issuance costs for fiscal 2023 was $1.55M, a 40.36% decline from fiscal 2022.
- Celularity Inc. payments of debt issuance costs for fiscal 2022 was $2.60M, a 76.03% decline from fiscal 2021.
- Celularity Inc. payments of debt issuance costs for fiscal 2021 was $10.86M, a 2595.29% increase from fiscal 2020.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 9 month as first filed | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $40.00K 10-K · filed 2026-04-30 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-08 | $260.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.55M 10-K · filed 2025-05-08 | ||
| 2023-09-30 | $260.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-06 | $1.55M 10-Q · filed 2024-12-06 | |||
| 2023-06-30 | $1.29M 10-Q · filed 2024-11-07 | ||||
| 2022-12-31 | -$150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $81.00K derived: sum of 2 quarters · filed 2024-07-30 | $2.60M 10-K · filed 2024-07-30 | ||
| 2022-09-30 | $231.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-03 | $2.75M 10-Q · filed 2024-01-03 | $2.55M 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | $2.52M 10-Q · filed 2023-08-14 | ||||
| 2021-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $5.02M derived: sum of 2 quarters · filed 2023-03-31 | $6.02M derived: sum of 3 quarters · filed 2023-03-31 | $10.86M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $3.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $4.59M derived: sum of 2 quarters · filed 2022-11-10 | $9.43M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $999.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $5.84M 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | $4.84M 10-Q · filed 2022-05-16 | ||||
| 2020-12-31 | $403.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |